Rafferty Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.43M | Buy |
|
|||||
|
2025
Q1 | $9.49M | Sell |
|
|||||
|
2024
Q4 | $13.7M | Buy |
|
|||||
|
2024
Q3 | $14.3M | Sell |
|
|||||
|
2024
Q2 | $18.7M | Buy |
|
|||||
|
2024
Q1 | $9.32M | Buy |
|
|||||
|
2023
Q4 | $9.31M | Sell |
|
|||||
|
2023
Q3 | $8.74M | Buy |
|
|||||
|
2023
Q2 | $7.88M | Buy |
|
|||||
|
2023
Q1 | $7.32M | Sell |
|
|||||
|
2022
Q4 | $8.15M | Buy |
|
|||||
|
2022
Q3 | $6.33M | Buy |
|
|||||
|
2022
Q2 | $4.21M | Sell |
|
|||||
|
2022
Q1 | $5.43M | Buy |
|
|||||
|
2021
Q4 | $5.49M | Buy |
|
|||||
|
2021
Q3 | $3.09M | Buy |
|
|||||
|
2021
Q2 | $2.65M | Sell |
|
|||||
|
2021
Q1 | $3.28M | Buy |
|
|||||
|
2020
Q4 | $1.03M | Sell |
|
|||||
|
2020
Q3 | $4.76M | Buy |
|
|||||
|
2020
Q2 | $3.93M | Sell |
|
|||||
|
2020
Q1 | $2.89M | Sell |
|
|||||
|
2019
Q4 | $6.55M | Sell |
|
|||||
|
2019
Q3 | $7.95M | Buy |
|
|||||
|
2019
Q2 | $7.46M | Buy |
|
|||||
|
2019
Q1 | $6.82M | Buy |
|
|||||
|
2018
Q4 | $1.58M | Sell |
|
|||||
|
2018
Q3 | $1.97M | Buy |
|
|||||
|
2018
Q2 | $1.65M | Sell |
|
|||||
|
2018
Q1 | $1.56M | Buy |
|
|||||
|
2017
Q4 | $1.41M | Sell |
|
|||||
|
2017
Q3 | $1.58M | Buy |
|
|||||
|
2017
Q2 | $1.47M | Buy |
|
|||||
|
2017
Q1 | $1.11M | Buy |
|
|||||
|
2016
Q4 | $977K | Buy |
|
|||||
|
2016
Q3 | $701K | Buy |
|
|||||
|
2016
Q2 | $545K | Sell |
|
|||||
|
2016
Q1 | $794K | Buy |
|
|||||
|
2015
Q4 | $876K | Buy |
|
|||||
|
2015
Q3 | $677K | Buy |
|